TY - JOUR
T1 - Localization of parathyroid adenoma by 11C-Choline PET/CT preliminary results
AU - Orevi, Marina
AU - Freedman, Nanette
AU - Mishani, Eyal
AU - Bocher, Moshe
AU - Jacobson, Orit
AU - Krausz, Yodphat
N1 - Publisher Copyright:
Copyright © 2014 Lippincott Williams & Wilkins.
PY - 2014/12
Y1 - 2014/12
N2 - Purpose: This prospective pilot study was aimed to evaluate 11C-choline PET/CT (choline) as a tool for localization of parathyroid adenoma (PTA). Methods: Forty patients with biochemical hyperparathyroidism underwent cho-line and 99mTc-MIBI imaging within a median interval of 56 days. Choline and MIBI images were analyzed and correlated with each other, with additional modalities such as ultrasound, CT, MRI, and with surgical findings, when available. Results: Thirty-seven of forty cases were choline-positive, and 3 were choline-negative. Choline uptake on PET was identified with corresponding nodules on CT of the PET/CT, yielding precise localization. Twenty of thirty-seven foci were located in typical sites in the neck, and 17 were ectopic. Clear visualization of PTA was achieved in 33 of 37, whereas findings in 4 cases were suspicious for PTA. MIBI was positive in 33 of 40 cases (22 clearly positive, 11 suspicious). In 29 of 40 cases, choline and MIBI were concordant, but choline findings were clearer in 9 of these 29 studies. At the time of writing, 27 patients had undergone surgery. In 24 cases, there was complete matching of choline with surgical findings of PTA. Overall in 23 cases, both choline and MIBI matched surgical findings of PTA. In1 case, PTAwas correctly localized on choline but not on MIBI, and in 2 cases, neither choline nor MIBI corresponded to the surgical findings. Conclusions: These preliminary results indicate that the combined functional and anatomical modality of choline PET/CT is a promising tool for PTA localization, providing clearer images than MIBI, equal or better accuracy, and quicker and easier acquisition.
AB - Purpose: This prospective pilot study was aimed to evaluate 11C-choline PET/CT (choline) as a tool for localization of parathyroid adenoma (PTA). Methods: Forty patients with biochemical hyperparathyroidism underwent cho-line and 99mTc-MIBI imaging within a median interval of 56 days. Choline and MIBI images were analyzed and correlated with each other, with additional modalities such as ultrasound, CT, MRI, and with surgical findings, when available. Results: Thirty-seven of forty cases were choline-positive, and 3 were choline-negative. Choline uptake on PET was identified with corresponding nodules on CT of the PET/CT, yielding precise localization. Twenty of thirty-seven foci were located in typical sites in the neck, and 17 were ectopic. Clear visualization of PTA was achieved in 33 of 37, whereas findings in 4 cases were suspicious for PTA. MIBI was positive in 33 of 40 cases (22 clearly positive, 11 suspicious). In 29 of 40 cases, choline and MIBI were concordant, but choline findings were clearer in 9 of these 29 studies. At the time of writing, 27 patients had undergone surgery. In 24 cases, there was complete matching of choline with surgical findings of PTA. Overall in 23 cases, both choline and MIBI matched surgical findings of PTA. In1 case, PTAwas correctly localized on choline but not on MIBI, and in 2 cases, neither choline nor MIBI corresponded to the surgical findings. Conclusions: These preliminary results indicate that the combined functional and anatomical modality of choline PET/CT is a promising tool for PTA localization, providing clearer images than MIBI, equal or better accuracy, and quicker and easier acquisition.
KW - C-choline
KW - Localization
KW - PET/CT
KW - Parathyroid adenoma
KW - Tc-MIBI
UR - http://www.scopus.com/inward/record.url?scp=84922394504&partnerID=8YFLogxK
U2 - 10.1097/RLU.0000000000000607
DO - 10.1097/RLU.0000000000000607
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 25290292
AN - SCOPUS:84922394504
SN - 0363-9762
VL - 39
SP - 1033
EP - 1038
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
IS - 12
ER -